# Association between dietary fiber intake and cancer cachexia: mediation by inflammatory biomarkers

**Authors:** Yan Guo, Caiyan Zhang, Haiyue Wang, Hongmei Xue, Ying Xie, Hongzhen Du, Zengning Li

PMC · DOI: 10.3389/fnut.2026.1757969 · Frontiers in Nutrition · 2026-02-05

## TL;DR

Higher dietary fiber intake is linked to lower cancer cachexia risk, partly due to reduced inflammation.

## Contribution

This study identifies dietary fiber's protective role against cancer cachexia and shows inflammation as a key mediator.

## Key findings

- Dietary fiber intake is inversely correlated with cancer cachexia risk (p < 0.001).
- Inflammatory markers WBC, NEU, and NLR mediate 5.67–7.78% of the effect of dietary fiber on cachexia.
- Greater fiber intake lowers cachexia risk (OR = 0.92, p = 0.007).

## Abstract

Cancer cachexia (CC) is a major cause of death in cancer patients, with chronic inflammation being a key driver. Dietary fiber, a nutrient with strong anti-inflammatory potential, is closely linked to mortality risk in cancer patients. However, the association between dietary fiber intake and cachexia risk remains unclear.

This study collected dietary and clinical data from cancer patients enrolled in the “Investigation for Current States of Dietary Intake and Its Influencing Factors in Patients with Common Cancers” (DIIFC). First, we analyzed the association between dietary fiber intake and cancer cachexia using restricted cubic splines (RCSs). Next, we used multivariable logistic regression models to analyze the relationships between dietary fiber intake, inflammatory markers, and cancer cachexia. Finally, we performed mediation analysis to explore whether inflammation mediates the effect of dietary fiber intake on cancer cachexia.

Of the 720 participants, 198 were diagnosed with cancer cachexia. RCSs revealed a nonlinear inverse correlation between dietary fiber intake and the risk of cancer cachexia (p < 0.001). Logistic regression analysis showed that greater dietary fiber intake was associated with a lower risk of cachexia (OR = 0.92, 95% CI: 0.87–0.98, p = 0.007). Higher levels of inflammatory markers (WBC, NEU, and NLR) were associated with a greater risk of cachexia (p < 0.05). Mediation analysis indicated that WBC, NEU, and NLR significantly mediated the relationship between dietary fiber and cachexia, accounting for 5.67%, 7.62%, and 7.78%, respectively (p < 0.05).

Increased dietary fiber intake may exert a protective effect against cancer cachexia, partially mediated through inflammatory pathways. Further exploration of specific fiber subtypes and additional mechanisms is warranted.

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** death (MESH:D003643), muscle catabolism (MESH:D019042), gastroesophageal and pancreatic cancers (MESH:D010190), Chronic inflammation (MESH:D007249), muscle atrophy (MESH:D009133), sarcopenia (MESH:D055948), metabolic disturbances (MESH:D024821), weight loss (MESH:D015431), digestive system cancer (MESH:D004067), anorexia (MESH:D000855), gynecological malignancies (MESH:D005833), lung cancer (MESH:D008175), infection (MESH:D007239), gastrointestinal discomfort (MESH:D005767), CC (MESH:D009369), gastrointestinal malignancies (MESH:D005770), Cachexia (MESH:D002100), muscle and fat loss (MESH:D009135), overweight (MESH:D050177), system (MESH:D015619), digestive malignancies (MESH:D004828), lymphoma (MESH:D008223), gastric and esophageal cancers (MESH:D013274), obese (MESH:D009765), breast and prostate cancers (MESH:D001943), skeletal muscle mass (MESH:C536030), chronic (MESH:D002908), infectious lesion (MESH:D003141)
- **Chemicals:** fiber (MESH:D004043), phytocompounds (-), propionate (MESH:D011422), butyrate (MESH:D002087), omega-3 fatty acids (MESH:D015525), HMB (MESH:C004961), SCFAs (MESH:D005232), acetate (MESH:D000085), BCAAs (MESH:D000597)
- **Species:** Bifidobacterium (genus) [taxon 1678], Homo sapiens (human, species) [taxon 9606], Bacteroides (genus) [taxon 816]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916402/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916402/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916402/full.md

---
Source: https://tomesphere.com/paper/PMC12916402